Search by Drug Name or NDC

    NDC 00008-0836-21 Effexor 150 mg/1 Details

    Effexor 150 mg/1

    Effexor is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. The primary component is VENLAFAXINE HYDROCHLORIDE.

    Product Information

    NDC 00008-0836
    Product ID 0008-0836_b736ba0d-415e-4d3f-bb94-543edc7a7007
    Associated GPIs 58180090107050
    GCN Sequence Number 046405
    GCN Sequence Number Description venlafaxine HCl CAP ER 24H 150 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 16818
    HICL Sequence Number 008847
    HICL Sequence Number Description VENLAFAXINE HCL
    Brand/Generic Brand
    Proprietary Name Effexor
    Proprietary Name Suffix XR
    Non-Proprietary Name VENLAFAXINE HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name VENLAFAXINE HYDROCHLORIDE
    Labeler Name Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
    Pharmaceutical Class Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020699
    Listing Certified Through 2024-12-31

    Package

    NDC 00008-0836-21 (00008083621)

    NDC Package Code 0008-0836-21
    Billing NDC 00008083621
    Package 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0008-0836-21)
    Marketing Start Date 1997-11-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 20.0119
    Pricing Unit EA
    Effective Date 2024-01-30
    NDC Description EFFEXOR XR 150 MG CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis